Luxembourg discovery advances Parkinson’s disease diagnosis

Scientists uncover paradigm-shifting immune cell markers for early Parkinson's detection with particular relevance to women

27-Nov-2023 - In a ground-breaking study, scientists from the Allergy and Clinical Immunology Research Team of the Luxembourg Institute of Health (LIH) Department of Infection and Immunity and the Transversal Translational Medicine of LIH, in collaboration with the Luxembourg Centre for Systems Biomedicine ...

Verici DX reaches a global licensing and commercialisation agreement with Thermo Fisher Scientific

Agreement grants rights to further develop an assay for pre-transplant prognostic testing

20-Nov-2023 - Verici Dx plc, a developer of advanced clinical diagnostics for organ transplant, announced that it has signed an exclusive global licensing agreement with Thermo Fisher Scientific to further develop an assay for pre-transplant prognostic testing for risk of early kidney rejection. The exclusive ...

Innovation in Nuclear Medicine: PET Signals in Brain Tumors Decoded at the Cellular Level for the First Time

01-Nov-2023 - Researchers in Munich have developed a new method that for the first time makes the signals of radioactive substances in cells in the brain visible using positron emission tomography (PET). In a study published in Science Advances, they applied the method to glioblastoma, the deadliest brain ...

AI and 10 seconds of voice can screen for diabetes

Scientists discover voice tech as potential game changer in Type 2 diabetes detection

24-Oct-2023 - Determining whether a person is diabetic could be as easy as having them speak a few sentences into their smartphone, according to a groundbreaking study from Klick Labs that combines voice technology with artificial intelligence in a major step forward in diabetes detection. The new study, ...

A miniature magnetic resonance imager made of diamond

Quantum sensors make microscale NMR spectroscopy possible

23-Oct-2023 - The development of tumors begins with miniscule changes within the body's cells; ion diffusion at the smallest scales is decisive in the performance of batteries. Until now the resolution of conventional imaging methods has not been high enough to represent these processes in detail. A research ...

Scientists develop novel nanoparticles that could serve as contrast agents

Special feature: The properties of these unique nanoparticles change in reaction to heat

20-Oct-2023 - Special nanoparticles could one day improve modern imaging techniques. Developed by researchers at Martin Luther University Halle-Wittenberg (MLU), the properties of these unique nanoparticles change in reaction to heat. When combined with an integrated dye, the particles may be used in ...

A Deep Learning Framework For High-Quality Optoacoustic Imaging in Real-Time

Helmholtz Munich and TU Munich further develop method together with spin-off iThera Medical

11-Oct-2023 - Researchers at Helmholtz Munich and the Technical University of Munich have made significant progress in advancing high-resolution optoacoustic imaging for clinical use. Their innovative deep-learning framework, known as DeepMB, holds great promise for patients dealing with a range of illnesses, ...

analytica 2024 presents the laboratory world of tomorrow

Focus topics are digitization and sustainability

11-Oct-2023 - The international laboratory industry will meet in person again in spring 2024 at analytica in Munich from April 9 to 12. The world’s leading trade fair for laboratory technology, analysis and biotechnology covers the entire spectrum of laboratories in industry and research, and places great ...

Nobel Prize in Physics 2023 goes to Pierre Agostini, Ferenc Krausz and Anne L'Huillier

The laureates’ contributions have enabled the investigation of processes that are so rapid they were previously impossible to follow

04-Oct-2023 - The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Physics 2023 to Pierre Agostini (The Ohio State University, Columbus, USA), Ferenc Krausz (Max Planck Institute of Quantum Optics, Garching and Ludwig-Maximilians-Universität München, Germany) and Anne L’Huillier (Lund ...

Beckman Coulter and Fujirebio enter into partnership

The goal is a patient-friendly, blood-based Alzheimer's disease test

22-Sep-2023 - Beckman Coulter Diagnostics and Fujirebio announced a new partnership combining their respective immunoassay strengths to support therapeutic development, clinical trials, reimbursement, and routine clinical adoption in the field of neurodegenerative diseases. The burden of disability and deaths ...